Our previous work demonstrated that TNFα, a mediator implicated in articular diseases such as osteoarthritis (OA), downregulates Cx43 levels in chondrocytes through proteasome activation, impacting both gap junction numbers and nuclear Cx43 expression [11]. The gene discussed is TNF; the disease is osteoarthritis.